Watts v. Medicis Pharm. Corp. – 1/21/2016
February 8, 2016
Arizona Supreme Court holds that, under the learned intermediary doctrine, a pharmaceutical manufacturer can satisfy its duty to warn by providing appropriate warnings to a prescribing physician; that the doctrine does not conflict with the Uniform Contribution Among Tortfeasors Act; and that the Consumer Fraud Act does not require a direct merchant-to-consumer transaction to support a patient’s statutory claim against a drug manufacturer.
